Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

314
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
314
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

173
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
173
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

281
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
281
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

263
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
263
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

181
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
181
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

54
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
54

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying subgroups of ICU patients with high mortality rates using machine learning: A nationwide, population-based study.

Journal of critical care·2026
Same author

Perceived Inappropriateness of Intensive Care Treatment Among Clinicians: A Cross-Sectional Nationwide Survey on the Prevalence, Associated Factors, and Outcomes.

Critical care medicine·2026
Same author

Paediatric patient experience during hospitalisation stays: Developing paediatric PREMS questionnaires through a collaborative Delphi study.

Acta psychologica·2026
Same author

Compositionality and systematicity emerge from iterated learning in deep linear networks.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors.

Journal of critical care·2026
Same author

Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2026

Related Experiment Video

Updated: Aug 17, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.4K

Adverse Events in Pediatric Critical Care Nonsurvivors With a Low Predicted Mortality Risk: A Multicenter Case

Carin W Verlaat1, Marieke Zegers1, Richard Klein2

  • 1Department of Intensive Care, Radboud University Medical Center, Nijmegen, The Netherlands.

Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
|December 15, 2022
PubMed
Summary

Adverse events significantly impact mortality in low-risk pediatric intensive care unit (PICU) nonsurvivors. Over 76% experienced adverse events, with 30% contributing to death, highlighting a critical area for intervention.

More Related Videos

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

848
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

11.6K

Related Experiment Videos

Last Updated: Aug 17, 2025

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
11:27

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn

Published on: April 7, 2023

6.4K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

848
How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children
07:27

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

11.6K

Area of Science:

  • Pediatric critical care medicine
  • Patient safety research
  • Clinical epidemiology

Background:

  • Some patients in the pediatric intensive care unit (PICU) with low predicted mortality risk do not survive.
  • The role of adverse events in the mortality of these low-risk nonsurvivors is not well understood.
  • Understanding these events is crucial for improving patient outcomes and safety protocols.

Purpose of the Study:

  • To determine the incidence of adverse events in low-risk nonsurvivors (LN) compared to low-risk survivors (LS) and high-risk PICU patients (survivors and nonsurvivors).
  • To assess the contribution of adverse events to mortality in the low-risk nonsurvivor group.
  • To identify specific types of adverse events prevalent in this population.

Main Methods:

  • A case-control study utilizing data from the Dutch national PICU registry (2006-2017).
  • Stratification of 53,789 PICU admissions into four groups: low-risk nonsurvivors (LN), low-risk survivors (LS), high-risk nonsurvivors (HN), and high-risk survivors (HS).
  • Random sampling of patients within each group, with adverse events identified using a validated trigger tool method via patient chart review.

Main Results:

  • A total of 419 patients were analyzed (102 LN, 107 LS, 104 HN, 106 HS).
  • Low-risk nonsurvivors (LN) exhibited a significantly higher occurrence of adverse events (76.5%) compared to LS (13.1%) and HN (47.1%).
  • Adverse events contributed to death in 30.4% of LN, with 8.8% deemed preventable. Hospital-acquired infections and drug/fluid-related events were most common in LN.

Conclusions:

  • Adverse events are frequent and significantly contribute to mortality among low-risk PICU nonsurvivors.
  • A substantial proportion of these adverse events are preventable, indicating potential targets for quality improvement initiatives.
  • These findings underscore the importance of vigilant monitoring and proactive safety measures even in patients predicted to have a low risk of mortality.